Description
HUMA Peptide JOINT FLX (TB-500 + BPC-157) 15 mg is an advanced dual-peptide research formulation developed for laboratories investigating the synergistic biological activity of TB-500 (Thymosin Beta-4 Fragment) and BPC-157 (Body Protection Compound-157). This premium blend combines two of the most extensively researched regenerative peptides, providing scientists with a comprehensive platform for exploring tissue remodeling, cellular migration, angiogenesis, connective tissue biology, and peptide-mediated repair mechanisms.
Supplied in a lyophilized 15 mg vial, JOINT FLX is manufactured to deliver exceptional purity, stability, and consistency for advanced laboratory applications. The carefully balanced combination of TB-500 and BPC-157 makes this formulation ideal for research involving tendon and ligament biology, musculoskeletal tissue studies, extracellular matrix signaling, and regenerative pathways in controlled scientific environments.
Produced under stringent quality standards, HUMA Peptide JOINT FLX is intended exclusively for laboratory and scientific research, delivering the precision and reliability expected by professionals in modern peptide science.
Key Features
- Advanced dual-peptide research blend
- Combines TB-500 and BPC-157 in one formulation
- Total peptide content: 15 mg per vial
- 1 lyophilized vial per pack
- High-purity research-grade formulation
- Commonly studied in regenerative biology and connective tissue research
- Suitable for investigations involving angiogenesis, cellular signaling, tissue remodeling, and musculoskeletal biology
- Manufactured under strict quality standards
- Intended exclusively for laboratory and scientific research applications
Contents
Active Ingredients:
- TB-500 (Thymosin Beta-4 Fragment)
- BPC-157 (Body Protection Compound-157)
Total Peptide Content: 15 mg
Packaging: 1 Lyophilized Vial
Reviews
There are no reviews yet.